UPM Biomedicals, the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications, announces the launch of FibGel™— a natural injectable hydrogel...
AbbVie and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric...
Alphina Therapeutics, a biotechnology company developing a best-in-class NAMPT inhibitor for the treatment of a range of solid tumor indications, announced that it has...
Integral Molecular, a leader in developing advanced technologies for the discovery of vaccines and therapeutics, is excited to announce a five-year, $8 million contract from...
Alpha-9 Oncology Inc, a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, announced an oversubscribed $175 million Series...
